Abstract
In the present article, structural, neurochemical and functional neuroimaging investigations performed on patients with social anxiety disorder were reviewed. A PubMed search was performed to identify all structural and functional neuroimaging studies published between 1980 and February 2013. The studies and case reports on neuroimaging in social anxiety disorder were grouped under the subheadings of structural, functional and magnetic resonance spectroscopic imaging. It seems that structural studies involve examination of abnormalities in the basal ganglia structures like caudate nucleus, thalamus, and putamen, hippocampus and amygdala abnormalities in summary. Neurochemical investigations reveal the deficiencies in the GABAergic system and over-activation in the glutamatergic system in social anxiety disorder. Functional neuroimaging investigations implicate the role of limbic-medial prefrontal circuit.
Keywords: Social anxiety disorder, neuroimaging, structural, functional, MRI.
Reviews on Recent Clinical Trials
Title:What About the Neuroimaging Findings in Social Anxiety Disorder?
Volume: 8 Issue: 2
Author(s): Murad Atmaca
Affiliation:
Keywords: Social anxiety disorder, neuroimaging, structural, functional, MRI.
Abstract: In the present article, structural, neurochemical and functional neuroimaging investigations performed on patients with social anxiety disorder were reviewed. A PubMed search was performed to identify all structural and functional neuroimaging studies published between 1980 and February 2013. The studies and case reports on neuroimaging in social anxiety disorder were grouped under the subheadings of structural, functional and magnetic resonance spectroscopic imaging. It seems that structural studies involve examination of abnormalities in the basal ganglia structures like caudate nucleus, thalamus, and putamen, hippocampus and amygdala abnormalities in summary. Neurochemical investigations reveal the deficiencies in the GABAergic system and over-activation in the glutamatergic system in social anxiety disorder. Functional neuroimaging investigations implicate the role of limbic-medial prefrontal circuit.
Export Options
About this article
Cite this article as:
Atmaca Murad, What About the Neuroimaging Findings in Social Anxiety Disorder?, Reviews on Recent Clinical Trials 2013; 8 (2) . https://dx.doi.org/10.2174/15748871113086660050
DOI https://dx.doi.org/10.2174/15748871113086660050 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hydroxamate, a Key Pharmacophore Exhibiting a Wide Range of Biological Activities
Mini-Reviews in Medicinal Chemistry Brain Functional Effects of Psychopharmacological Treatments in Schizophrenia: A Network-based Functional Perspective Beyond Neurotransmitter Systems
Current Neuropharmacology Pharmacodynamics of Memantine: An Update
Current Neuropharmacology Huntingtons Disease: New Frontiers for Molecular and Cell Therapy
Current Drug Targets Suicide in Parkinson’s Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets Adenosine in the Inflamed Gut: A Janus Faced Compound
Current Medicinal Chemistry Early-phase 18F-AV-45 PET Imaging can Detect Crossed Cerebellar Diaschisis Following Carotid Artery Stenosis and Cerebral Hypoperfusion
Current Neurovascular Research From Nature to Drug Discovery: The Indole Scaffold as a ‘Privileged Structure’
Mini-Reviews in Medicinal Chemistry Parkinsons Disease and Obsessive-Compulsive Phenomena: A Systematic Review
Current Psychiatry Reviews Chronic HIV-1 Tat and HIV Reduce Rbfox3/NeuN: Evidence for Sex- Related Effects
Current HIV Research Contemporary Anticholinesterase Pharmaceuticals of Natural Origin and Their Synthetic Analogues for the Treatment of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Neurotrophic and Neuroprotective Effects of Muscle Contraction
Current Pharmaceutical Design Conceptual Issues in Psychiatric Neuroimaging: An Update
Current Topics in Medicinal Chemistry Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders
Current Neuropharmacology Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology Regulation of Dopamine Signaling in the Striatum by Phosphodiesterase Inhibitors: Novel Therapeutics to Treat Neurological and Psychiatric Disorders
Central Nervous System Agents in Medicinal Chemistry Neuropeptides as Possible Targets in Sleep Disorders: Special Emphasis on Hypocretin-Deficient Narcolepsy
CNS & Neurological Disorders - Drug Targets Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
Current Medicinal Chemistry Update On Emerging Antivirals For The Management Of Herpes Simplex Virus Infections: A Patenting Perspective
Recent Patents on Anti-Infective Drug Discovery Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
CNS & Neurological Disorders - Drug Targets